最新心血管治疗药物综述PPT课件.ppt

《最新心血管治疗药物综述PPT课件.ppt》由会员分享，可在线阅读，更多相关《最新心血管治疗药物综述PPT课件.ppt（83页珍藏版）》请在淘文阁 - 分享文档赚钱的网站上搜索。

1、心血管治疗药物综述心血管治疗药物综述TopicsElectrophysiologyVaughn-Williams classificationAntihypertensivesHemostatic agentsFast Potential-80-60-40-200+20RMP-80to90mVPhase 1Phase 2Phase 3Phase 4controlled by Na+channels=“fast channels”Fast PotentialPhase 0:Na+influx“fast sodium channels”Phase 1:K+effluxPhase 2:(Platea

2、u)K+efflux AND Ca+influxPhase 3:K+effluxPhase 4:Resting Membrane PotentialCardiac Conduction CycleSlow Potential-80-60-40-200Phase4Phase3dependent upon Ca+channels=“slow channels”Slow PotentialSelf-depolarizingResponsible for automaticityPhase 4 depolarizationslow sodium-calcium channelsleaky to sod

3、iumPhase 3 repolarizationK+effluxCardiac Pacemaker DominanceIntrinsic firing rates:SA=60 100 AV=45 60Purkinje=15-45Cardiac PacemakersSA is primaryFaster depolarization rateFaster Ca+leakOthers are backupsGraduated depolarization rateGraduated Ca+leak ratePotential TermsAPDERPRRPrelative refractorype

4、riodeffective refractory periodaction potential durationDysrhythmia GenerationAbnormal genesisImbalance of ANS stimuliPathologic phase 4 depolarizationEctopic fociDysrhythmia GenerationAbnormal conductionAnalogies:One way valveBuggies stuck in muddy roadsReentrant CircuitsWarning!All antidysrhythmic

5、s have arrythmogenic propertiesIn other words,they all can CAUSE dysrhythmias too!AHA Recommendation ClassificationsDescribes weight of supporting evidence NOT mechanismClass IClass IIaClass IIb IndeterminantClass IIIView AHA definitionsVaughn-Williams ClassificationClass 1IaIbIcClass IIClass IIICla

6、ss IVMiscDescription of mechanism NOT evidenceClass I:Sodium Channel BlockersDecrease Na+movement in phases 0 and 4Decreases rate of propagation(conduction)via tissue with fast potential(Purkinje)Ignores those with slow potential(SA/AV)Indications:ventricular dysrhythmiasClass Ia AgentsSlow conducti

7、on through ventriclesDecrease repolarization rateWiden QRS and QT intervalsMay promote Torsades des Pointes!PDQ:procainamide(Pronestyl)disopyramide(Norpace)qunidine(Quinidex)Class Ib AgentsSlow conduction through ventriclesIncrease rate of repolarizationReduce automaticityEffective for ectopic fociM

8、ay have other usesLTMD:lidocaine(Xylocaine)tocainide(Tonocard)mexiletine(Mexitil)phenytoin(Dilantin)Class Ic AgentsSlow conduction through ventricles,atria&conduction systemDecrease repolarization rateDecrease contractilityRare last chance drugflecainide(Tambocor)propafenone(Rythmol)Class II:Beta Bl

9、ockersBeta1 receptors in heart attached to Ca+channelsGradual Ca+influx responsible for automaticityBeta1 blockade decreases Ca+influxEffects similar to Class IV(Ca+channel blockers)Limited#approved for tachycardiasClass II:Beta Blockerspropranolol(Inderal)acebutolol(Sectral)esmolol(Brevibloc)Class

10、III:Potassium Channel BlockersDecreases K+efflux during repolarizationProlongs repolarizationExtends effective refractory periodPrototype:bretyllium tosylate(Bretylol)Initial norepi discharge may cause temporary hypertension/tachycardiaSubsequent norepi depletion may cause hypotensionClass IV:Calciu

11、m Channel BlockersSimilar effect as blockersDecrease SA/AV automaticityDecrease AV conductivityUseful in breaking reentrant circuitPrime side effect:hypotension&bradycardiaverapamil(Calan)diltiazem(Cardizem)Note:nifedipine doesnt work on heartMisc.Agentsadenosine(Adenocard)Decreases Ca+influx&increa

12、ses K+efflux via 2nd messenger pathwayHyperpolarization of membraneDecreased conduction velocity via slow potentialsNo effect on fast potentialsProfound side effects possible(but short-lived)Misc.AgentsCardiac Glycocidesdigoxin(Lanoxin)Inhibits NaKATP pumpIncreases intracellular Ca+via Na+-Ca+exchan

13、ge pumpIncreases contractilityDecreases AV conduction velocityPharmacologyAntihypertensivesAntihypertensive Classesdiureticsbeta blockersangiotensin-converting enzyme(ACE)inhibitors calcium channel blockersvasodilatorsBlood Pressure=CO X PVRCardiac Output=SV x HRPVR=AfterloadBP=CO x PVRKey:CCB=calci

14、um channel blockersCA Adrenergics=central-acting adrenergicsACEis=angiotensin-converting enzyme inhibitorscardiacfactorscirculatingvolumeheartratecontractility1.Beta Blockers2.CCBs3.C.A.AdrenergicssaltaldosteroneACEisDiureticsBP=CO x PVRHormones1.vasodilators2.ACEIs3.CCBs CentralNervousSystem1.CA Ad

15、renergicsPeripheralSympatheticReceptorsalphabeta1.alpha blockers 2.beta blockersLocalActing1.Peripheral-Acting AdrenergicsAlpha1 BlockersStimulate alpha1 receptors-hypertensionBlock alpha1 receptors-hypotensiondoxazosin(Cardura)prazosin(Minipress)terazosin(Hytrin)Central Acting AdrenergicsStimulate

16、alpha2 receptors inhibit alpha1 stimulationhypotensionclonidine(Catapress)methyldopa(Aldomet)Peripheral Acting Adrenergicsreserpine(Serpalan)inhibits the release of NEdiminishes NE storesleads to hypotensionProminent side effect of depressionalso diminishes seratoninAdrenergic Side EffectsCommondry

17、mouth,drowsiness,sedation&constipationorthostatic hypotensionLess commonheadache,sleep disturbances,nausea,rash&palpitationsAngiotensinIACEAngiotensinII1.1.potent vasoconstrictor-increases BP2.stimulates Aldosterone-Na+&H2OreabsorbtionACE Inhibitors.RAASRenin-Angiotensin Aldosterone SystemAngiotensi

18、n II =vasoconstrictorConstricts blood vessels&increases BPIncreases SVR or afterloadACE-I blocks these effects decreasing SVR&afterloadACE InhibitorsAldosterone secreted from adrenal glands cause sodium&water reabsorptionIncrease blood volumeIncrease preloadACE-I blocks this and decreases preloadAng

19、iotensin Converting Enzyme Inhibitorscaptopril(Capoten)enalapril(Vasotec)lisinopril(Prinivil&Zestril)quinapril(Accupril)ramipril(Altace)benazepril(Lotensin)fosinopril(Monopril)Calcium Channel BlockersUsed for:AnginaTachycardiasHypertensionCCB Site of Actiondiltiazem&verapamilnifedipine(and otherdihy

20、dropyridines)CCB Actiondiltiazem&verapamildecrease automaticity&conduction in SA&AV nodesdecrease myocardial contractilitydecreased smooth muscle tonedecreased PVRnifedipinedecreased smooth muscle tonedecreased PVRSide Effects of CCBsCardiovascularhypotension,palpitations&tachycardiaGastrointestinal

21、constipation&nauseaOtherrash,flushing&peripheral edemaCalcium Channel Blockersdiltiazem(Cardizem)verapamil(Calan,Isoptin)nifedipine(Procardia,Adalat)Diuretic Site of Action.loop of HenleproximaltubuleDistal tubuleCollecting ductMechanismWater follows Na+20-25%of all Na+is reabsorbed into the blood s

22、tream in the loop of Henle5-10%in distal tubule&3%in collecting ductsIf it can not be absorbed it is excreted with the urine Blood volume=preload!Side Effects of Diureticselectrolyte losses Na+&K+fluid losses dehydrationmyalgiaN/V/DdizzinesshyperglycemiaDiureticsThiazides:chlorothiazide(Diuril)&hydr

23、ochlorothiazide(HCTZ,HydroDIURIL)Loop Diureticsfurosemide(Lasix),bumetanide(Bumex)Potassium Sparing Diureticsspironolactone(Aldactone)Mechanism of VasodilatorsDirectly relaxes arteriole smooth muscleDecrease SVR=decrease afterload Side Effects of Vasodilatorshydralazine(Apresoline)Reflex tachycardia

24、sodium nitroprusside(Nipride)Cyanide toxicity in renal failureCNS toxicity=agitation,hallucinations,etc.Vasodilatorsdiazoxide Hyperstathydralazine Apresolineminoxidil Lonitensodium Nitroprusside NipridePharmacologyDrugs Affecting HemostasisHemostasisReproduce figure 11-9,page 359 Sherwood Platelet A

25、dhesionCoagulation CascadeReproduce following components of cascade:Prothrombin-thrombin Fibrinogen-fibrinPlasminogen-plasminPlatelet InhibitorsInhibit the aggregation of plateletsIndicated in progressing MI,TIA/CVASide Effects:uncontrolled bleedingNo effect on existing thrombi AspirinInhibits COXAr

26、achidonic acid(COX)-TXA2(aggregation)GP IIB/IIIA InhibitorsGP GP IIIIb/b/IIIIIIa aInhibitorsInhibitorsFibrinogenGP GP IIIIb/b/IIIIIIa aReceptorReceptorGP IIB/IIIA Inhibitorsabciximab(ReoPro)eptifibitide(Integrilin)tirofiban(Aggrastat)AnticoagulantsInterrupt clotting cascade at various pointsNo effec

27、t on plateletsHeparin&LMW Heparin(Lovenox)warfarin(Coumadin)HeparinEndogenousReleased from mast cells/basophilsBinds with antithrombin IIIAntithrombin III binds with and inactivates excess thrombin to regionalize clotting activity.Most thrombin(80-95%)captured in fibrin mesh.Antithrombin-heparin com

28、plex 1000X as effective as antithrombin III aloneHeparinMeasured in Units,not milligramsIndications:MI,PE,DVT,ischemic CVAAntidote for heparin OD:protamine.MOA:heparin is strongly negatively charged.Protamine is strongly positively charged.warfarin(Coumadin)Factors II,VII,IX and X all vitamin K depe

29、ndent enzymesWarfarin competes with vitamin K in the synthesis of these enzymes.Depletes the reserves of clotting factors.Delayed onset(12 hours)due to existing factorsThrombolyticsDirectly break up clotsPromote natural thrombolysisEnhance activation of plasminogenTime is Musclestreptokinase(Strepta

30、se)alteplase(tPA,Activase)anistreplase(Eminase)reteplase(Retevase)tenecteplase(TNKase)Occlusion MechanismtPA MechanismCholesterol MetabolismCholesterol important component in membranes and as hormone precursorSynthesized in liverHydroxymethylglutaryl coenzyme A reductase(HMG CoA reductase)dependantS

31、tored in tissues for latter useInsoluble in plasma(a type of lipid)Must have transport mechanismLipoproteinsLipids are surrounded by protein coat to hide hydrophobic fatty core.Lipoproteins described by densityVLDL,LDL,IDL,HDL,VHDLLDL contain most cholesterol in bodyTransport cholesterol from liver

32、to tissues for use(“Bad”)HDL move cholesterol back to liver“Good”b/c remove cholesterol from circulationWhy We Fear CholesterolRisk of CAD linked to LDL levelsLDLs are deposited under endothelial surface and oxidized where they:Attracts monocytes-macrophagesMacrophages engulf oxidized LDLVacuolation

33、 into foam cellsFoam cells protrude against intimal liningEventually a tough cap is formedVascular diameter&blood flow decreasedWhy We Fear CholesterolPlaque cap can ruptureCollagen exposedClotting cascade activatedPlatelet adhesionThrombus formationEmbolus formation possibleOcclusion causes ischemi

34、aLipid DepositionThrombus FormationPlatelet AdhesionEmbolus FormationOcclusion Causes InfarctionAntihyperlipidemic AgentsGoal:Decrease LDLInhibition of LDL synthesisIncrease LDL receptors in liverTarget:200 mg/dlStatins are HMG CoA reductase inhibitorslovastatin(Mevacor)pravastatin(Pravachol)simvastatin(Zocor)atorvastatin(Lipitor)结束语结束语谢谢大家聆听！谢谢大家聆听！83